Progressive Disease
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11967 | Binimetinib | 1 | Terminated | 1 |
DB12267 | Brigatinib | 1 | Terminated | 1 |
DB12483 | Copanlisib | 1 | Active Not Recruiting | 1 |
DB14865 | Human interleukin-2 | 1 | Recruiting | 1 |
DB11793 | Niraparib | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB00002 | Cetuximab | 1 / 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Withdrawn | 1 |
DB12109 | Devimistat | 1 / 2 | Withdrawn | 1 |
DB11718 | Encorafenib | 1 / 2 | Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Withdrawn | 1 |
DB01611 | Hydroxychloroquine | 1 / 2 | Withdrawn | 1 |
DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
DB00026 | Anakinra | 2 | Recruiting | 1 |
DB11945 | Avelumab | 2 | Completed | 1 |
DB13915 | Axicabtagene ciloleucel | 2 | Recruiting | 1 |
DB06626 | Axitinib | 2 | Completed | 1 |
DB11666 | Buparlisib | 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB13985 | Lutetium Lu 177 dotatate | 2 | Recruiting | 1 |
DB14797 | SEphB4-HSA | 2 | Active Not Recruiting | 1 |